The role of irisin in glycemic control is still unclear but it may be reasonable to hypothesize that lower levels of circulating irisin in patients with T2D may be due to impaired PGC-1α expression and functions in their muscle tissue [2]. Here, PPARGC1A is linked to type 2 diabetes mellitus.